VRS
Virginia Retirement Systems Portfolio holdings
AUM
$14.5B
This Quarter Return
+11.65%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$14.5B
AUM Growth
+$1.02B
(+7.6%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
28.35%
Holding
1,108
New
93
Increased
375
Reduced
324
Closed
176
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$60.9M |
| 2 |
VICI Properties
VICI
|
$58.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
$56M |
| 4 |
Dollar General
DG
|
$51.6M |
| 5 |
Albertsons Companies
ACI
|
$41.1M |
Top Sells
| 1 |
Walmart
WMT
|
$82.9M |
| 2 |
Cheniere Energy
LNG
|
$80.5M |
| 3 |
McKesson
MCK
|
$61.5M |
| 4 |
Cisco
CSCO
|
$52.9M |
| 5 |
NVIDIA
NVDA
|
$50.9M |
Sector Composition
| 1 | Technology | 29.96% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Communication Services | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Green Brick Partners
GRBK
$3.14B
| $204K | ﹤0.01% |
3,242
-5,000
| -61% | -$314K |
|
902
Amphastar Pharmaceuticals
AMPH
$1.36B
| $201K | ﹤0.01% |
8,762
-800
| -8% | -$18.4K |
|
903
Liberty Energy
LBRT
$1.74B
| $199K | ﹤0.01% |
17,305
-29,900
| -63% | -$343K |
|
904
Avanos Medical
AVNS
$587M
| $192K | ﹤0.01% |
15,704
+100
| +0.6% | +$1.22K |
|
905
Viridian Therapeutics
VRDN
$1.52B
| $180K | ﹤0.01% |
12,900
-5,300
| -29% | -$74.1K |
|
906
Hertz
HTZ
$1.69B
| $180K | ﹤0.01% |
+26,300
| New | +$180K |
|
907
Bumble
BMBL
$672M
| $177K | ﹤0.01% |
+26,900
| New | +$177K |
|
|
AVDL
908
Avadel Pharmaceuticals
AVDL
$1.46B
| $176K | ﹤0.01% |
19,900
+2,400
| +14% | +$21.2K |
|
909
The RealReal
REAL
$1B
| $175K | ﹤0.01% |
+36,500
| New | +$175K |
|
910
CleanSpark
CLSK
$2.55B
| $174K | ﹤0.01% |
15,800
-4,700
| -23% | -$51.8K |
|
911
Aurora
AUR
$10.3B
| $171K | ﹤0.01% |
32,600
-37,300
| -53% | -$195K |
|
912
Intellia Therapeutics
NTLA
$1.25B
| $166K | ﹤0.01% |
17,742
+900
| +5% | +$8.44K |
|
913
Ginkgo Bioworks
DNA
$691M
| $149K | ﹤0.01% |
13,200
| – | – |
|
914
Orthofix Medical
OFIX
$581M
| $147K | ﹤0.01% |
+13,200
| New | +$147K |
|
915
Huntsman Corp
HUN
$1.92B
| $147K | ﹤0.01% |
14,100
-1,500
| -10% | -$15.6K |
|
916
Nurix Therapeutics
NRIX
$697M
| $141K | ﹤0.01% |
12,400
-3,600
| -23% | -$41K |
|
917
Planet Labs
PL
$1.96B
| $140K | ﹤0.01% |
23,000
-20,100
| -47% | -$123K |
|
918
Capricor Therapeutics
CAPR
$272M
| $135K | ﹤0.01% |
13,600
+3,200
| +31% | +$31.8K |
|
919
Liberty Latin America Class C
LILAK
$1.63B
| $132K | ﹤0.01% |
21,189
-18,100
| -46% | -$113K |
|
920
Newmark Group
NMRK
$3.17B
| $131K | ﹤0.01% |
10,800
-2,700
| -20% | -$32.8K |
|
921
Udemy
UDMY
$1.01B
| $126K | ﹤0.01% |
+17,900
| New | +$126K |
|
922
Axogen
AXGN
$709M
| $118K | ﹤0.01% |
+10,900
| New | +$118K |
|
923
Hope Bancorp
HOPE
$1.44B
| $116K | ﹤0.01% |
+10,800
| New | +$116K |
|
924
Riot Platforms
RIOT
$4.86B
| $113K | ﹤0.01% |
10,000
| – | – |
|
925
Arbutus Biopharma
ABUS
$769M
| $112K | ﹤0.01% |
36,300
-3,300
| -8% | -$10.2K |
|